BCDA

Companies
NASDAQ
BioCardia, Inc.
Health Care
Price Chart
Overview

About BCDA

we are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. biocardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its cardiamp™ and cardiallo™ therapies. clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. these programs are enabled by the company's helix™ transendocardial delivery systems and morph® vascular access products, which are partnered to enable other promising biotherapeutic programs.

Market Cap
$6.8M
Volume
206.2K
Avg. Volume
195.2K
P/E Ratio
-1.5433072
Dividend Yield
0.00%
Employees
28.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.19
Low Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BCDA.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BCDA shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$6.8M
Volume206.2K
P/E Ratio-1.54
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 15, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how BCDA fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025